Cerebral palsy screening

Revision as of 16:41, 6 October 2017 by Aditya Ganti (talk | contribs) (→‎Screening)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Cerebral palsy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cerebral Palsy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cerebral palsy screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cerebral palsy screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cerebral palsy screening

CDC on Cerebral palsy screening

Cerebral palsy screening in the news

Blogs on Cerebral palsy screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cerebral palsy screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

There is insufficient evidence to recommend routine screening for cerebral palsy. Serial follow-up exams of all newborns from neonatal intensive care are warranted until it is evident that there is no failure in developmental milestones or development of spasticity.

Screening

  • There is insufficient evidence to recommend routine screening for cerebral palsy.
  • Serial follow-up exams of all newborns from neonatal intensive care are warranted until it is evident that there is no failure in developmental milestones or development of spasticity.[1]

References

  1. Upasani VV, Ketwaroo PD, Estroff JA, Warf BC, Emans JB, Glotzbecker MP (2016). "Prenatal diagnosis and assessment of congenital spinal anomalies: Review for prenatal counseling". World J Orthop. 7 (7): 406–17. doi:10.5312/wjo.v7.i7.406. PMC 4945507. PMID 27458551.

Template:WH Template:WS